Symphony has reported solid H1 earnings with gross profit up and losses reduced. Momentum continued throughout the period, with a notably strong Q2 performance. The balance sheet is also in better shape helped by a recent successful £1.3m equity fundraising. Improved performance was driven primarily by recovery in demand for the d2w (biodegradable) product, and tight control of costs. The outlook is cautious but positive with a growing pipeline for both d2w and d2p (protective technology) produc ....